Standardization of Molecular Monitoring for Chronic Myeloid Leukemia: 2021 Update-Reference-Cited by-同舟云学术

Standardization of Molecular Monitoring for Chronic Myeloid Leukemia: 2021 Update

Published:2021 Issue: Volume: Page:105-117
ISSN:2197-9766
Container-title:Hematologic Malignancies
language:
Short-container-title:

Author:

Salmon Matthew,White Helen E.,Cross Nicholas C. P.,Hochhaus Andreas

Publisher

Springer International Publishing

Link

https://link.springer.com/content/pdf/10.1007/978-3-030-71913-5_8

Reference69 articles.

1. Hughes T, et al. False-positive results with PCR to detect leukaemia-specific transcript. Lancet. 1990;335(8696):1037–8.

2. Sawyers CL, et al. Molecular relapse in chronic myelogenous leukemia patients after bone marrow transplantation detected by polymerase chain reaction. Proc Natl Acad Sci U S A. 1990;87(2):563–7.

3. Gabert J, et al. Detection of residual bcr/abl translocation by polymerase chain reaction in chronic myeloid leukaemia patients after bone-marrow transplantation. Lancet. 1989;2(8672):1125–8.

4. Hughes TP, Goldman JM. Biological importance of residual leukaemic cells after BMT for CML: does the polymerase chain reaction help? Bone Marrow Transplant. 1990;5(1):3–6.

5. Cross NC, et al. Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: correlations with acute graft-versus-host disease and relapse. Br J Haematol. 1993;84(1):67–74.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review on characterization of BCR – ABL transcript variants for molecular monitoring of chronic myeloid leukemia phenotypes;Hematology;2023-11-20

2. Measurable residual disease in chronic myeloid leukemia;Haematologica;2022-12-01